…fee, and exclusion from the requirement to offer discounted prices to certain covered entities under the 340B program.  According to the preamble, certain of the comments identified plasma protein therapies,…

…date of suspension. The preamble clarifies that a suspension of the NRA would not affect the manufacturer’s obligations under the 340B drug discount program or reimbursement under Medicare Part B….

…D context, HHS OIG plans to assess “Medicare Part D Rebates Related to Drugs Dispensed by 340B Pharmacies” and billing for topical compounded drugs. HHS OIG also plans to review…

…and lower ceiling prices under the 340B drug discount program. Comments on this ANPRM are due to CMS no later than 5:00 pm on December 31, 2018. We will be…

…drugs increased to 22.1% of AMP and rebates increased for new formulations  (§ 1742) Rebates required for drugs dispensed to Medicaid managed care enrollees (§ 1743) 340B Program Program expanded…

…drugs under the 340B Drug Discount Program or under Medicare Part B. 3. Restatements Pursuant to Internal Investigations Under the MDRP, manufacturers must restate incorrect AMPs and best prices and…

…the Senate bill contains major changes to the Medicaid Rebate Program, Medicaid drug reimbursement, Medicare Part D, the 340B Drug Discount Program, and the Federal Food, Drug, and Cosmetic Act,…

…In a prior post, we commented that, in enacting previous government discount programs in the early 1990s (the Medicaid Drug Rebate Program, the 340B drug discount program, and the VA…

…experience working with: Price calculation and reporting under the Medicaid Drug Rebate Program and the 340B Drug Discount Program Average sales price reporting under Medicare Part B Price reporting and…

…Basics for Community Pharmacists The ABCs of 340B Federal Regulation Affecting the Practice of Nuclear Pharmacy Pharmacy’s Impact on Disparities in Research Pharmacists and Patient-Centered Diabetes Care Updates in Alzheimer’s…